Galbraith Kenneth's Form 4 filing
Zymeworks Inc. (ZYME) · filed Jan 6, 2025
- Accession no.
- 0000950170-25-002497
- Filed
- Jan 6, 2025
- Trade date
- Jan 6, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $854.8K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Galbraith KennethCIK 0001567045 | Director, Officer (Chair & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | Common Stock | MOption exerciseAcquired | +47,666 | $0.00 | $0 | 71,428 | Direct | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −23,885 | $14.92 | −$356,364.2 | 47,543 | Direct | |
| Jan 6, 2025 | Common Stock | MOption exerciseAcquired | +66,666 | $0.00 | $0 | 114,209 | Direct | |
| Jan 6, 2025 | Common Stock | SSaleDisposed | −33,406 | $14.92 | −$498,417.52 | 80,803 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | Common Stock | MOption exerciseDisposed | −47,666 | $0.00 | $0 | 47,668 | Direct | |
| Jan 6, 2025 | Common Stock | MOption exerciseDisposed | −66,666 | $0.00 | $0 | 133,334 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.